Skip to main content
Clinical Trials/ACTRN12623000710628
ACTRN12623000710628
Recruiting
未知

Antenatal screening for first trimester cytomegalovirus (CMV) infection: a pilot study

niversity of Melbourne0 sites70 target enrollmentJuly 4, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Maternal primary infection with cytomegalovirus
Sponsor
niversity of Melbourne
Enrollment
70
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 4, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversity of Melbourne

Eligibility Criteria

Inclusion Criteria

  • The inclusion criteria for participation in this study are as follows: individuals must be 18 years of age or older, have tested negative for CMV IgG on their antenatal booking bloods performed before 9 weeks and 6 days of gestation, and be no more than 14 weeks and 0 days pregnant at the time of recruitment. Additionally, participants must have the capacity to provide informed consent for medical procedures and either be fluent in English or have access to a qualified interpreter who can explain the study protocol and assist in obtaining informed consent. Furthermore, individuals must have a planned birth at the Mercy Hospital for Women in Victoria, Australia.

Exclusion Criteria

  • The exclusion criteria for participation in this study are as follows: individuals who are younger than 18 years of age are not eligible to participate. Participants who are unable to provide informed consent for medical procedures will be excluded. Individuals who are at or beyond 14 weeks and 0 days of gestation at the time of recruitment are not eligible for inclusion. Lastly, individuals who have a known fetal anomaly in the current pregnancy are not eligible to participate.

Outcomes

Primary Outcomes

Not specified

Similar Trials